This degradation, in turn, allows NF-B activity to increase, resulting in increased transcription of pro-inflammatory genes, including TNF-, IL-1, IL-6, and inducible nitric oxide synthase (iNOS) (Morgan and Liu, 2011)
It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication
AEDG peptide and histones H1/3, H1/6 binding may be one of the mechanisms which provides an increase of Nestin, GAP43, Tubulin III, and Doublecortin neuronal differentiation gene transcription
The Canadian healthcare system does not cover peptide therapy as an approved treatment, so all costs come out of pocket
You can compare the standalone BPC-157 and TB-500 pages directly, or start from the full healing peptides category to see the broader recovery lineup